These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38098337)
1. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1. Martínez-López A; García-Casas A; Infante G; González-Fernández M; Salvador N; Lorente M; Mendiburu-Eliçabe M; Gonzalez-Moreno S; Villarejo-Campos P; Velasco G; Malliri A; Castillo-Lluva S Mol Oncol; 2024 Mar; 18(3):620-640. PubMed ID: 38098337 [TBL] [Abstract][Full Text] [Related]
2. POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway. Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J Exp Cell Res; 2020 May; 390(1):111933. PubMed ID: 32142855 [TBL] [Abstract][Full Text] [Related]
3. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462 [TBL] [Abstract][Full Text] [Related]
4. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101 [TBL] [Abstract][Full Text] [Related]
6. RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3. Zhou K; Rao J; Zhou ZH; Yao XH; Wu F; Yang J; Yang L; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF Lab Invest; 2018 Aug; 98(8):989-998. PubMed ID: 29884911 [TBL] [Abstract][Full Text] [Related]
7. SUMOylation of the GTPase Rac1 is required for optimal cell migration. Castillo-Lluva S; Tatham MH; Jones RC; Jaffray EG; Edmondson RD; Hay RT; Malliri A Nat Cell Biol; 2010 Nov; 12(11):1078-85. PubMed ID: 20935639 [TBL] [Abstract][Full Text] [Related]
8. RAB4A GTPase regulates epithelial-to-mesenchymal transition by modulating RAC1 activation. Karthikeyan S; Casey PJ; Wang M Breast Cancer Res; 2022 Oct; 24(1):72. PubMed ID: 36307864 [TBL] [Abstract][Full Text] [Related]
9. The Ratio of RAC1B to RAC1 Expression in Breast Cancer Cell Lines as a Determinant of Epithelial/Mesenchymal Differentiation and Migratory Potential. Eiden C; Ungefroren H Cells; 2021 Feb; 10(2):. PubMed ID: 33567745 [TBL] [Abstract][Full Text] [Related]
10. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways. Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893 [TBL] [Abstract][Full Text] [Related]
11. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells. Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412 [TBL] [Abstract][Full Text] [Related]
12. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways. Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422 [TBL] [Abstract][Full Text] [Related]
13. FilGAP, a GAP for Rac1, down-regulates invadopodia formation in breast cancer cells. Saito K; Ozawa S; Chiba Y; Takahashi R; Ogomori R; Mukai K; Taguchi T; Hatakeyama H; Ohta Y Cell Struct Funct; 2023 Sep; 48(2):161-174. PubMed ID: 37482421 [TBL] [Abstract][Full Text] [Related]
14. Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines. Cardama GA; Comin MJ; Hornos L; Gonzalez N; Defelipe L; Turjanski AG; Alonso DF; Gomez DE; Menna PL Anticancer Agents Med Chem; 2014; 14(6):840-51. PubMed ID: 24066799 [TBL] [Abstract][Full Text] [Related]
15. The involvement of mutant Rac1 in the formation of invadopodia in cultured melanoma cells. Revach OY; Winograd-Katz SE; Samuels Y; Geiger B Exp Cell Res; 2016 Apr; 343(1):82-88. PubMed ID: 26873115 [TBL] [Abstract][Full Text] [Related]
16. Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion. Sedgwick AE; Clancy JW; Olivia Balmert M; D'Souza-Schorey C Sci Rep; 2015 Oct; 5():14748. PubMed ID: 26458510 [TBL] [Abstract][Full Text] [Related]
17. RASAL2 activates RAC1 to promote triple-negative breast cancer progression. Feng M; Bao Y; Li Z; Li J; Gong M; Lam S; Wang J; Marzese DM; Donovan N; Tan EY; Hoon DS; Yu Q J Clin Invest; 2014 Dec; 124(12):5291-304. PubMed ID: 25384218 [TBL] [Abstract][Full Text] [Related]
18. Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion. Díaz J; Mendoza P; Ortiz R; Díaz N; Leyton L; Stupack D; Quest AF; Torres VA J Cell Sci; 2014 Jun; 127(Pt 11):2401-6. PubMed ID: 24659799 [TBL] [Abstract][Full Text] [Related]
19. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis. Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334 [TBL] [Abstract][Full Text] [Related]
20. Epigenetically upregulated GEFT-derived invasion and metastasis of rhabdomyosarcoma via epithelial mesenchymal transition promoted by the Rac1/Cdc42-PAK signalling pathway. Liu C; Zhang L; Cui W; Du J; Li Z; Pang Y; Liu Q; Shang H; Meng L; Li W; Song L; Wang P; Xie Y; Wang Y; Liu Y; Hu J; Zhang W; Li F EBioMedicine; 2019 Dec; 50():122-134. PubMed ID: 31761617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]